The GLI3 gene helps control how a baby’s body is patterned before birth, especially the hands, feet, face, and brain. This gene plays an important role in turning growth signals on or off at the right time. When a harmful variant disrupts that control, a person may be born with extra fingers or toes, fused digits, or other differences in development, sometimes as part of Greig cephalopolysyndactyly syndrome or Pallister-Hall syndrome. GLI3 is better known in genetics clinics than in everyday culture.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do much of the work. Other genes mainly help direct when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To explore this topic in greater depth, you can find more in the LearnHub.
Overview
GLI3Gene function
What if the gene works
The GLI3 gene helps guide early body development. It controls how cells respond to growth signals, especially in the hands, feet, face, and brain, so tissues form in the right place and pattern.
Risk
What if the gene does not work
Variants in the GLI3 gene can disrupt early body patterning, often causing extra or fused fingers or toes. Milder to more severe variants may also affect head shape, facial development, the brain, airway, hormones, and growth.
Treatment
What does that mean for your treatment
No treatment or management approach specific to pathogenic variants in the GLI3 gene is currently established. The GLI3 gene is being studied as part of the hedgehog signaling pathway as a possible biomarker or drug target in some cancers, but this does not currently guide routine treatment for conditions linked to the GLI3 gene.
Conditions associated with GLI3
Gene function
What if the gene works
Early in development, the GLI3 gene helps growing tissues read position and timing signals. Its protein works as a control switch for many other genes, especially in the Sonic Hedgehog pathway, a system that guides body layout before birth. This supports orderly growth as organs and limbs take shape.
GLI3 helps turn many other genes up or down as tissues grow. This lets cells follow the right plan at the right time during early development.
Inside developing tissues, the GLI3 gene helps cells respond to Sonic Hedgehog, a signal that guides growth before birth. It can either hold back or support gene activity depending on how strong that signal is.
GLI3 helps give cells a sense of place as the body forms. That is a core part of GLI3 gene function in limb, face, and brain development.
GLI3 helps balance cell growth with the start of specialization, when cells begin taking on specific jobs. This supports more orderly building of tissues and organs.
What is a variant?
A genetic variant is a slight change in the DNA code within a gene. These changes are common and help explain normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GLI3 gene can change the protein’s shape, stability, or ability to control other genes during early development. Some changes only partly reduce its activity, while more severe loss-of-function variants can leave too little working protein, and certain shortening variants create an abnormally short protein with altered effects. This helps explain how GLI3 gene variants affect development, with milder or more severe changes linked to different patterns and timing of features, including Pallister-Hall syndrome and Greig cephalopolysyndactyly syndrome.
How variants are linked to conditions
Pathogenic variants in the GLI3 gene cause Greig cephalopolysyndactyly syndrome and Pallister-Hall syndrome. GLI3 gene variants and related conditions can also include isolated polydactyly, meaning an extra finger or toe without the full syndrome pattern. The exact features often vary from person to person, depending on the specific variant.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology, and they are widespread across the general population. Most do not directly affect health and simply contribute to normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences are part of the picture. Still, in some situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GLI3, risk is mainly shaped by whether a disease-causing variant is inherited or happens for the first time in a child; lifestyle factors are not known to meaningfully change the chance of these GLI3-related conditions. If a GLI3 variant is already present, care usually focuses on early checks for related features and treating any complications.
Inheritance of GLI3 variants
Variants in the GLI3 gene are usually inherited in an autosomal dominant pattern for well-established GLI3-related conditions. This means a person only needs one altered copy of the GLI3 gene to have the condition, and an affected parent can pass it to each child with a 50% chance. Some GLI3 gene variants happen as a new, de novo change, so the condition can appear in a child without either parent carrying the same variant. This is the main GLI3 inheritance pattern described in families.
What does my GLI3 result mean for my family?
For well-known GLI3-related conditions, the family pattern is usually dominant, so a parent, brother, sister, or child may also carry the same gene change. Each child of someone with a disease-causing GLI3 variant can have a 1 in 2, or 50%, chance of inheriting it. Some GLI3 changes happen new in one person, so a parent may not have the variant.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the GLI3 gene, genetic testing for GLI3 variants uses DNA from a blood or saliva sample. A lab usually reads the gene's code by sequencing and may also check for missing or extra pieces, which can help confirm whether a variant is present.
When should I consider getting a genetic test?
A GLI3 test may be worth considering if you or your child has a pattern of birth differences such as extra fingers or toes, joined fingers or toes, or unusually broad thumbs or big toes, especially if these run in the family. It can also help when doctors suspect Greig syndrome or Pallister-Hall syndrome.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best interpreted together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help make personal experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug faster or slower than expected, so the same dose may work better for one person and less well for another. Variants can also make someone more or less likely to notice side effects. This kind of difference is common and helps explain why medication response is often not the same from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way people respond to medications. It studies gene-drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. You can explore this topic in more detail in the LearnHub.
Drugs influenced by the GLI3 gene
When should I seek medical advice?
There is not currently a broadly confirmed role for this gene in predicting how medicines will work or which side effects may happen. Questions about symptoms, treatment choices, or medicine side effects are best discussed with your doctor or pharmacist.
History
In recent decades, awareness of the GLI3 gene’s role has grown through research on inherited differences in limb and skull development. It was identified in the early 1990s, during a period when scientists were connecting specific genes to recognizable family patterns and childhood conditions. Soon afterward, changes in the GLI3 gene were linked to Greig cephalopolysyndactyly syndrome and later to Pallister-Hall syndrome, helping explain why these features can run in families. From these first observations, research expanded steadily. Studies in mice and other laboratory models then showed that GLI3 was part of a broader developmental pathway, which made it an important gene in human genetics and birth defect research.